• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数严重降低的心率控制型心房颤动的导管消融:针对节律异常介导的心肌病的干预措施

Catheter ablation in rate-controlled atrial fibrillation with severely reduced ejection fraction: intervention for irregularity-mediated cardiomyopathy.

作者信息

Maidman Samuel D, Aizer Anthony, Jankelson Lior, Holmes Douglas, Park David S, Bernstein Scott A, Knotts Robert, Kushnir Alex, Chinitz Larry A, Barbhaiya Chirag R

机构信息

Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, NYU Langone Health, 403 E 34Th Street, 4Th Floor, New York, NY, 10016, USA.

出版信息

J Interv Card Electrophysiol. 2025 Jun;68(4):857-864. doi: 10.1007/s10840-024-01965-x. Epub 2024 Dec 19.

DOI:10.1007/s10840-024-01965-x
PMID:39702550
Abstract

BACKGROUND

Recent evidence suggests atrial fibrillation (AF) causes cardiomyopathy due to remodeling driven by both irregular rate and rhythm. Atrial fibrillation (AF) ablation in patients with reduced ejection fraction (EF) ≤ 35% has been shown to improve EF and mortality. It is unknown whether the benefits of AF ablation among patients with reduced EF are affected by the degree of pre-ablation rate control.

OBJECTIVES

To evaluate AF ablation echocardiographic outcomes for patients who have EF ≤ 35% with varying degrees of pre-ablation rate control.

METHODS

Single-center, retrospective study of patients with EF ≤ 35% undergoing first-time ablation of persistent AF. Primary analyses evaluated the degree to which pre-ablation rate control impacted echocardiographic outcomes. Rates of EF recovery to > 35% were compared at three different cutoffs: 110 bpm, 90 bpm, and 70 bpm. A linear regression analysis was then performed to evaluate whether baseline heart rate (HR) predicted change in EF.

RESULTS

Among 73 patients, the mean pre-ablation resting HR was 90 ± 25 bpm, and baseline EF was 27 ± 7%. Patients experienced significant improvements in EF by mean + 14% ± 11% (p < 0.001). Post-ablation EF recovery occurred in 60% of patients. No differences in EF improvement were detected at HR control targets of ≤ 110 bpm or ≤ 90 bpm, while patients achieving HR ≤ 70 bpm had less improvement in EF (+ 9% ± 9%) compared to those with HR above the cutoff (+ 16% ± 11%; p = 0.01). Linear regression analysis did not reveal baseline HR as a significant predictor of change in LVEF (slope = 0.09, r = 0.05, p = 0.07).

CONCLUSIONS

Catheter ablation of persistent AF in patients with reduced EF frequently resulted in recovery in EF > 35%, irrespective of pre-ablation achieved rate control. While patients with HR > 70 bpm experienced a greater improvement in EF compared to those ≤ 70 bpm, patients with baseline HR below this target still experienced significant EF improvements. Further investigation into irregularity-mediated cardiomyopathy is warranted.

摘要

背景

最近的证据表明,心房颤动(AF)由于不规则的心率和节律驱动的重塑而导致心肌病。射血分数(EF)≤35%的患者进行心房颤动(AF)消融已被证明可改善EF和降低死亡率。尚不清楚EF降低的患者中AF消融的益处是否受消融前心率控制程度的影响。

目的

评估EF≤35%且消融前心率控制程度不同的患者的AF消融超声心动图结果。

方法

对EF≤35%且首次进行持续性AF消融的患者进行单中心回顾性研究。主要分析评估消融前心率控制对超声心动图结果的影响程度。在三个不同的心率临界值(110次/分、90次/分和70次/分)下比较EF恢复至>35%的比率。然后进行线性回归分析,以评估基线心率(HR)是否可预测EF的变化。

结果

73例患者中,消融前静息HR平均为90±25次/分,基线EF为27±7%。患者的EF平均显著改善了+14%±11%(p<0.001)。60%的患者消融后EF恢复。在心率控制目标≤110次/分或≤90次/分的情况下,未检测到EF改善的差异,而心率≤70次/分的患者与心率高于临界值的患者相比,EF改善较少(+9%±9%)(+16%±11%;p=0.01)。线性回归分析未显示基线HR是左心室射血分数(LVEF)变化的显著预测因素(斜率=0.09,r=0.05,p=0.07)。

结论

EF降低的患者进行持续性AF导管消融通常会使EF恢复至>35%,无论消融前的心率控制情况如何。虽然心率>70次/分的患者与心率≤70次/分的患者相比,EF改善更大,但基线心率低于该目标的患者EF仍有显著改善。有必要对不规则介导的心肌病进行进一步研究。

相似文献

1
Catheter ablation in rate-controlled atrial fibrillation with severely reduced ejection fraction: intervention for irregularity-mediated cardiomyopathy.射血分数严重降低的心率控制型心房颤动的导管消融:针对节律异常介导的心肌病的干预措施
J Interv Card Electrophysiol. 2025 Jun;68(4):857-864. doi: 10.1007/s10840-024-01965-x. Epub 2024 Dec 19.
2
Non-invasive prediction of atrial cardiomyopathy characterized by multipolar high-density contact mapping.基于多极高密度接触标测的心房心肌病无创预测
J Interv Card Electrophysiol. 2025 Feb 3. doi: 10.1007/s10840-025-02001-2.
3
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
4
Effects of Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: Insights From CABANA.射血分数保留的心力衰竭患者行房颤消融术的效果:来自CABANA研究的见解
JACC Heart Fail. 2025 May;13(5):785-794. doi: 10.1016/j.jchf.2025.01.029. Epub 2025 Apr 16.
5
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
6
Direct-to-catheter ablation versus second line catheter ablation for persistent atrial fibrillation: Effect on arrhythmia recurrence, AF burden, early left atrium remodeling and quality of life.直接导管消融与二线导管消融治疗持续性心房颤动:对心律失常复发、房颤负荷、早期左心房重塑及生活质量的影响。
J Interv Card Electrophysiol. 2025 Jun;68(4):787-793. doi: 10.1007/s10840-024-01916-6. Epub 2024 Sep 12.
7
Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis.导管消融治疗左心室收缩功能障碍患者的心房颤动:系统评价和荟萃分析。
J Card Fail. 2011 Nov;17(11):964-70. doi: 10.1016/j.cardfail.2011.07.009. Epub 2011 Sep 9.
8
Different Approaches to Atrial Fibrillation Ablation in Heart Failure Patients: Temporal Trends and Clinical Outcomes.心力衰竭患者心房颤动消融的不同方法:时间趋势和临床结果。
JACC Clin Electrophysiol. 2025 May;11(5):942-952. doi: 10.1016/j.jacep.2024.12.004. Epub 2025 Jan 29.
9
Effects of atrial fibrillation ablation on arrhythmia burden and ventricular function in end-stage heart failure: Lessons from CASTLE-HTx.心房颤动消融术对终末期心力衰竭患者心律失常负荷及心室功能的影响:来自CASTLE-HTx研究的经验教训
Eur J Heart Fail. 2025 Feb;27(2):255-263. doi: 10.1002/ejhf.3505. Epub 2024 Oct 24.
10
Catheter ablation for paroxysmal and persistent atrial fibrillation.阵发性和持续性心房颤动的导管消融术
Cochrane Database Syst Rev. 2012 Apr 18;2012(4):CD007101. doi: 10.1002/14651858.CD007101.pub2.

本文引用的文献

1
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.终末期心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2023 Oct 12;389(15):1380-1389. doi: 10.1056/NEJMoa2306037. Epub 2023 Aug 27.
2
His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study-The ALTERNATIVE-AF trial.房室结消融术后伴射血分数降低的心房颤动患者行希氏束起搏与双心室起搏的比较:一项多中心、随机、交叉研究——ALTERNATIVE-AF 试验。
Heart Rhythm. 2022 Dec;19(12):1948-1955. doi: 10.1016/j.hrthm.2022.07.009. Epub 2022 Jul 14.
3
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
4
Multiple procedure outcomes for nonparoxysmal atrial fibrillation: Left atrial posterior wall isolation versus stepwise ablation.非阵发性心房颤动的多种手术结果:左心房后壁隔离与逐步消融。
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3117-3123. doi: 10.1111/jce.14771. Epub 2020 Oct 18.
5
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.心力衰竭伴射血分数恢复:JACC 科学专家小组。
J Am Coll Cardiol. 2020 Aug 11;76(6):719-734. doi: 10.1016/j.jacc.2020.05.075.
6
Atrial Fibrillation-Mediated Cardiomyopathy.心房颤动相关性心肌病。
Circ Arrhythm Electrophysiol. 2019 Dec;12(12):e007809. doi: 10.1161/CIRCEP.119.007809. Epub 2019 Dec 12.
7
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
8
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.2017年美国心脏协会/美国心脏病学会/心律学会室性心律失常患者管理和心脏性猝死预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组和心律学会的报告
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220. doi: 10.1016/j.jacc.2017.10.054. Epub 2018 Aug 16.
9
Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.导管消融与房颤伴收缩功能障碍的药物心率控制:CAMERA-MRI 研究。
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961. doi: 10.1016/j.jacc.2017.08.041. Epub 2017 Aug 27.
10
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.导管消融术与胺碘酮治疗心力衰竭伴植入装置患者持续性心房颤动的疗效比较:AATAC多中心随机试验结果
Circulation. 2016 Apr 26;133(17):1637-44. doi: 10.1161/CIRCULATIONAHA.115.019406. Epub 2016 Mar 30.